Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

Total article views   Abstract views HTML views PDF downloads Totals
8,462 Dovepress* 6,501 408+ 1,699 6,909
PubMed Central* 17 1,536 572 1,553
Totals 6,518 1,944 2,271 8,462
*Since 23 December 2011
+Since July 2016

View citations on PubMed Central and Google Scholar